Pimozide Recruiting Phase 2 Trials for Amyotrophic Lateral Sclerosis (ALS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03272503A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)